Literature DB >> 23436430

Changes in mortality and causes of death in the Swedish Down syndrome population.

Annika Englund1, Björn Jonsson, Cecilia Soussi Zander, Jan Gustafsson, Göran Annerén.   

Abstract

During the past few decades age at death for individuals with Down syndrome (DS) has increased dramatically. The birth frequency of infants with DS has long been constant in Sweden. Thus, the prevalence of DS in the population is increasing. The aim of the present study was to analyze mortality and causes of death in individuals with DS during the period 1969-2003. All individuals with DS that died between 1969 and 2003 in Sweden, and all individuals born with DS in Sweden between 1974 and 2003 were included. Data were obtained from the Swedish Medical Birth Register, the Swedish Birth Defects Register, and the National Cause of Death Register. Median age at death has increased by 1.8 years per year. The main cause of death was pneumonia. Death from congenital heart defects decreased. Death from atherosclerosis was rare but more frequent than reported previously. Dementia was not reported in any subjects with DS before 40 years of age, but was a main or contributing cause of death in 30% of the older subjects. Except for childhood leukemia, cancer as a cause of death was rare in all age groups. Mortality in DS, particularly infant mortality, has decreased markedly during the past decades. Median age at death is increasing and is now almost 60 years. Death from cancer is rare in DS, but death from dementia is common.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23436430     DOI: 10.1002/ajmg.a.35706

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  45 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  DS-Connect: A Promising Tool to Improve Lives and Engage Down Syndrome Communities Worldwide.

Authors:  Emmanuel K Peprah; Melissa A Parisi; Lisa Kaeser; Sujata Bardhan; MaryLou Oster-Granite; Yvonne T Maddox
Journal:  Glob Heart       Date:  2015-08-11

3.  Stem cells: Down's syndrome link to ageing.

Authors:  George P Souroullas; Norman E Sharpless
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

4.  Cause of death in adults with Down syndrome in the United States.

Authors:  Scott D Landes; J Dalton Stevens; Margaret A Turk
Journal:  Disabil Health J       Date:  2020-06-10       Impact factor: 2.554

5.  Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.

Authors:  Eric Doran; David Keator; Elizabeth Head; Michael J Phelan; Ron Kim; Minodora Totoiu; Jorge R Barrio; Gary W Small; Steven G Potkin; Ira T Lott
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Influence of CHDs on psycho-social and neurodevelopmental outcomes in children with Down syndrome.

Authors:  Jeannie Visootsak; Lillie Huddleston; Allison Buterbaugh; Adrienne Perkins; Stephanie Sherman; Jessica Hunter
Journal:  Cardiol Young       Date:  2015-02-16       Impact factor: 1.093

7.  Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.

Authors:  Eleonore Bayen; Katherine L Possin; Yingjia Chen; Laurent Cleret de Langavant; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

8.  Differentiating Aging Among Adults With Down Syndrome and Comorbid Dementia or Psychopathology.

Authors:  Anna J Esbensen; Emily Boshkoff Johnson; Joseph L Amaral; Christine M Tan; Ryan Macks
Journal:  Am J Intellect Dev Disabil       Date:  2016-01

9.  Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.

Authors:  Oguzhan Alagoz; Ali Hajjar; Sarocha Chootipongchaivat; Nicolien T van Ravesteyn; Jennifer M Yeh; Mehmet Ali Ergun; Harry J de Koning; Brian Chicoine; Barry Martin
Journal:  J Gen Intern Med       Date:  2019-08-05       Impact factor: 5.128

Review 10.  Skeletal dynamics of Down syndrome: A developing perspective.

Authors:  Jonathan M LaCombe; Randall J Roper
Journal:  Bone       Date:  2019-12-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.